8 pending office actions • 7 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 17 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (12%) |
| §101 + other | 1 (12%) |
| §103 only | 3 (38%) |
| §112 only | 1 (12%) |
| Double-patenting only | 1 (12%) |
| Double-patenting + other | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PADUA, NICO LAUREN | 1 | 14.3% | +30.7% |
| ISLAM, MOHAMMAD K | 1 | 82.9% | +16.9% |
| ARNOLD, ERNST V | 1 | 48.1% | +12.9% |
| MELLER, MICHAEL V | 1 | 47.2% | +28.1% |
| GONZALEZ, LUISALBERTO | 1 | 61.2% | +44.9% |
| MEYERS, ELIZABETH ANNE | 1 | 28.6% | +90.9% |
| BASQUILL, SEAN M | 1 | 38.8% | +21.6% |
| JANG, JAEICK | 1 | 66.7% | +51.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18704352 | APPARATUS AND METHOD FOR USING A PRODUCT HAVING AN IN-USE EXPIRY DATE | PADUA, NICO LAUREN | 53d |
| 18704036 | APPARATUS FOR ADMINISTERING MEDICAMENTS AND METHOD FOR MANAGING EXPIRY DATES OF A MEDICAMENT DISPENSER | ISLAM, MOHAMMAD K | — |
| 18203381 | Pharmaceutical Compositions and Methods for Stabilizing the Same | MEYERS, ELIZABETH ANNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17801067 | PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED PHARMACEUTICAL FORMULATION | JANG, JAEICK | 12d |
| 18631588 | CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS | ARNOLD, ERNST V | 30d |
| 18551942 | 8-CYCLO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS | GONZALEZ, LUISALBERTO | 48d |
| 18704352 | APPARATUS AND METHOD FOR USING A PRODUCT HAVING AN IN-USE EXPIRY DATE | PADUA, NICO LAUREN | 53d |
| 18576170 | PROCESS FOR THE PREPARATION OF A PULMONARY SURFACTANT | MELLER, MICHAEL V | 69d |
| 18704036 | APPARATUS FOR ADMINISTERING MEDICAMENTS AND METHOD FOR MANAGING EXPIRY DATES OF A MEDICAMENT DISPENSER | ISLAM, MOHAMMAD K | — |
| 18203381 | Pharmaceutical Compositions and Methods for Stabilizing the Same | MEYERS, ELIZABETH ANNE | — |
| 18030153 | A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER | BASQUILL, SEAN M | — |
| Art Unit | Apps |
|---|---|
| 3626 | 1 |
| 1613 | 1 |
| 1655 | 1 |
| 1624 | 1 |
| 1622 | 1 |
| 1614 | 1 |
| 3785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18704352 | APPARATUS AND METHOD FOR USING A PRODUCT HAVING AN IN-USE EXPIRY DATE | PADUA, NICO LAUREN | 3626 | §101§103 | Non-Final OA | 53d | Pending | Apr 24, 2024 |
| 18704036 | APPARATUS FOR ADMINISTERING MEDICAMENTS AND METHOD FOR MANAGING EXPIRY DATES OF A MEDICAMENT DISPENSER | ISLAM, MOHAMMAD K | — | §101 | Non-Final OA | — | Pending | Apr 23, 2024 |
| 18631588 | CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS | ARNOLD, ERNST V | 1613 | DP | Final Rejection | 30d | Pending | Apr 10, 2024 |
| 18576170 | PROCESS FOR THE PREPARATION OF A PULMONARY SURFACTANT | MELLER, MICHAEL V | 1655 | §103 | Non-Final OA | 69d | Pending | Jan 03, 2024 |
| 18551942 | 8-CYCLO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS | GONZALEZ, LUISALBERTO | 1624 | §112 | Non-Final OA | 48d | Pending | Sep 22, 2023 |
| 18203381 | Pharmaceutical Compositions and Methods for Stabilizing the Same | MEYERS, ELIZABETH ANNE | 1622 | §112DP | Non-Final OA | — | Pending | May 30, 2023 |
| 18030153 | A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER | BASQUILL, SEAN M | 1614 | §103Other | Final Rejection | — | Pending | Apr 04, 2023 |
| 17801067 | PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED PHARMACEUTICAL FORMULATION | JANG, JAEICK | 3785 | §103 | Final Rejection | 12d | Pending | Aug 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial